Social media and pharmacovigilance: A review of the opportunities and challenges
- 2 September 2015
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 80 (4) , 910-920
Abstract
Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.Keywords
Funding Information
- European Union's Seventh Framework Programme (FP7/2007-2013)
This publication has 45 references indexed in Scilit:
- Social and News Media Enable Estimation of Epidemiological Patterns Early in the 2010 Haitian Cholera OutbreakThe American Journal of Tropical Medicine and Hygiene, 2012
- Identifying potential adverse effects using the web: A new approach to medical hypothesis generationJournal of Biomedical Informatics, 2011
- Social Media and Networks in PharmacovigilanceDrug Safety, 2011
- Using Facebook to Increase Spontaneous Reporting of Adverse Drug ReactionsDrug Safety, 2011
- Detecting Vital Signs with Wearable Wireless SensorsSensors, 2010
- Smart Vest: Wearable multi-parameter remote physiological monitoring systemMedical Engineering & Physics, 2007
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Quantitative Methods in PharmacovigilanceDrug Safety, 2003
- An active learning framework for content-based information retrievalIEEE Transactions on Multimedia, 2002